An information article for FeelGood Psychology Clients
Mast Cell Activation Syndrome, usually shortened to MCAS, is a medical condition involving repeated episodes of excessive release of chemicals from particular immune cells. Alongside physical symptoms, some people report anxiety, low mood, disrupted sleep and difficulty thinking clearly, although researchers are still investigating how these experiences are connected.
Understanding these connections requires care: psychological symptoms may reflect biological processes, the demands of living with illness, other conditions, or several influences together. A helpful approach takes both physical and emotional experiences seriously, without assuming that one explains away the other.
What Are Mast Cells?
Mast cells are a type of white blood cell that forms part of the immune system, with particularly large numbers found in the skin, lungs and intestines. They develop from cells originating in bone marrow and settle in tissues, where they help the body respond to infection, injury and other challenges.
When activated, mast cells release substances called mediators, including histamine, tryptase and inflammatory signalling chemicals. These substances help coordinate protective responses, influence blood vessels and contribute to inflammation and tissue repair. Mast cells are therefore useful and necessary; difficulties arise when their activation or chemical release becomes excessive or inappropriate.
Many people know histamine through its role in allergic reactions, but mast cells can respond to more than allergens: certain medicines, infections, physical stimuli and emotional stress can also influence their activity. Their effects vary depending on which chemicals are released and which tissues are involved.
What Happens in MCAS?
MCAS involves recurring episodes of mast-cell activation affecting more than one body system, potentially producing combinations of flushing, hives, abdominal cramping, diarrhoea, wheezing or low blood pressure. Some episodes can involve anaphylaxis, a severe and potentially life-threatening reaction.
MCAS is not the same as mastocytosis, which involves an abnormal accumulation of mast cells; MCAS concerns their activation and mediator release, although the conditions can overlap. Nor does experiencing fatigue, anxiety or food-related symptoms, by itself, establish MCAS, because these difficulties have many possible explanations.
Widely accepted diagnostic criteria require characteristic recurrent episodes, laboratory evidence of increased mast-cell mediator release, and improvement with treatment targeting those mediators. Assessment usually involves comparing tryptase blood levels during a reaction with levels when the person is well, alongside investigating alternative explanations. Careful diagnosis helps direct treatment towards the most likely causes.
A Diagnosis Gaining Attention
MCAS is a relatively recent diagnostic concept: proposed criteria were published in 2010, followed by an international consensus framework in 2012. Research and clinical discussion have expanded since then, with diagnostic standards continuing to be reviewed in 2026.
Specialists report increasing referrals for suspected MCAS, while greater awareness and access to online information have brought the condition to wider public attention. However, more referrals and more frequent use of the diagnosis do not necessarily mean the underlying condition itself is becoming more common.
An important complication is that clinicians do not always use the same diagnostic framework: some apply established, stricter criteria, while others favour broader definitions. ASCIA, the Australasian Society of Clinical Immunology and Allergy, cautions that some people receive the label without meeting consensus criteria. This uncertainty supports thorough investigation—not dismissal of symptoms, and not premature certainty about their cause.
The Immune–Nervous System Connection
Mast cells communicate with nerves and release substances capable of influencing inflammatory processes, making their possible involvement in emotional and cognitive symptoms biologically plausible. Researchers are exploring pathways involving immune signalling, nerve sensitivity and the regulation of the brain’s protective barriers.
However, much of the mechanistic evidence comes from laboratory research, animal studies or conditions other than MCAS. These findings offer useful directions for investigation, but they do not establish precisely why a particular person experiences anxiety, depression or brain fog.
Stress can also influence mast-cell activity, creating the possibility of a two-way relationship between physical symptoms and emotional strain. Recognising this interaction does not demonstrate that stress originally caused someone’s MCAS, or that symptoms can be resolved simply through relaxation. Stress-management strategies are better understood as possible supports within broader care, rather than a test of whether someone is managing illness “correctly”.
Anxiety And Panic-Like Sensations
Anxiety is frequently reported in research involving people diagnosed with MCAS. In a 2025 questionnaire study comparing 553 adults with MCAS and 558 controls, approximately 66% of female participants with MCAS reported anxiety disorder, compared with approximately 30% of female controls.
These findings need context: participants were recruited through specialist practices, psychological outcomes were self-reported, and the study accepted both stricter and broader MCAS definitions. The results demonstrate an association within that sample, not proof that MCAS caused anxiety or that these percentages apply to everyone with the condition.
Physical reactions can also include a fast heartbeat, dizziness and breathing difficulties—sensations that may resemble panic or understandably provoke fear. Medical reactions and anxiety can coexist, so assessment should consider both rather than automatically choosing one explanation. Having an agreed medical action plan can provide a clearer framework for responding when symptoms occur.
Low Mood And Emotional Adjustment
Depression was also more commonly reported in the 2025 study: approximately 59% of female MCAS participants reported depression disorder, compared with approximately 30% of female controls. Again, these were questionnaire-based findings rather than independently verified psychiatric diagnoses for every participant.
Possible biological contributions remain under investigation, while the emotional consequences of ongoing illness are also important. Across chronic conditions, people may experience grief about changes in health, frustration about limitations, uncertainty about the future or concern about relationships and work.
For some, receiving a diagnosis brings relief; for others, adjustment involves mixed and changing emotions. These responses need not be treated as personal shortcomings, but persistent depression still deserves attention rather than being accepted as an unavoidable part of physical illness. Psychological care can support adjustment while medical investigation and treatment continue.
Brain Fog, Fatigue And Sleep
“Brain fog” is an everyday expression for difficulties with concentration, memory, word-finding or mental organisation, and these experiences are reported in MCAS research. Fatigue, insomnia and sensitivities to light, sound or odours have also been described.
Such symptoms can make ordinary tasks more demanding, but they are not specific to MCAS and should not automatically be attributed to mast cells. Their assessment may need to consider sleep, coexisting medical conditions, psychological wellbeing and treatment effects.
Support can be practical as well as therapeutic: written reminders, manageable commitments and asking others for assistance are reasonable adaptations when capacity fluctuates. These adjustments need not mean abandoning independence or meaningful goals. The aim is to reduce unnecessary demands while preserving activities and relationships that matter.
Personality And Changes In Behaviour
It is important to distinguish personality from how someone functions while unwell: personality refers to relatively enduring patterns of thinking, feeling and behaving. Current MCAS research does not establish a distinctive “MCAS personality”, nor does the 2025 symptom study demonstrate that MCAS causes personality disorders.
Some participants reported anger-related difficulties, but these findings describe an association, not a universal characteristic or diagnostic feature. Reports of irritability, withdrawal or reduced patience should therefore be considered alongside symptoms, sleep, distress and the person’s wider circumstances.
For example, declining social invitations might reflect symptom management, fear following previous reactions, exhaustion or low mood—not simply a loss of interest in other people. Asking what has changed, and what support would help, is generally more constructive than making assumptions about character. Equally, new or marked changes in behaviour warrant assessment rather than being automatically explained by an existing diagnosis.
Support Without Blame
The emotional burden of unpredictable reactions is increasingly recognised: a 2026 systematic review of adults with anaphylaxis found difficulties involving anxiety, depression, social participation and fear of future reactions. This review was not specific to MCAS, but it offers relevant insight into the demands of living with potentially serious episodes.
Medical management may include identifying triggers, medicines targeting mast-cell mediators, and an anaphylaxis action plan where indicated. Some people report improvements in psychological symptoms following mast-cell-directed treatment, but questionnaire studies and small case series cannot establish how reliably this occurs or which treatments are responsible.
Alongside medical care, psychological support can help with uncertainty, grief, anxiety, communication and maintaining valued parts of life. It should not require a person to deny physical symptoms, ignore medically necessary precautions or demonstrate constant positivity.
For FeelGood Psychology clients, a useful starting point is a conversation about what feels most difficult and what would make daily life more manageable.
This article provides general information, not an individual diagnosis. Sudden breathing difficulty, throat swelling or collapse requires emergency assessment; follow any prescribed anaphylaxis action plan and call 000 rather than assuming the symptoms are anxiety.
Article is written with the assistance of Perplexity AI.

